Cytochrome P450 polypeptide with increased enzyme activity

US9765307B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9765307-B2
Application numberUS-201514601162-A
CountryUS
Kind codeB2
Filing dateJan 20, 2015
Priority dateJan 20, 2014
Publication dateSep 19, 2017
Grant dateSep 19, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention pertains to an isolated P450 enzyme comprising or consisting of an amino acid sequence at least 80% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at position corresponding to position 225 and/or an aspartic acid mutation at position corresponding to position 289. The invention also concerns an isolated nucleic acid comprising a sequence encoding said enzyme, a vector comprising said nucleic acid, and a host cell containing said nucleic acid or said vector. Methods for preparing said enzyme and methods for producing steroid hormone precursors using the enzyme or the host cells featured in the invention are also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. An isolated P450 enzyme comprising an amino acid sequence at least 97% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at a position corresponding to position 225 and/or an aspartic acid at a position corresponding to position 289. 2. The enzyme according to claim 1 comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3. 3. The enzyme according to claim 1 consisting of the sequence SEQ ID NO: 1. 4. A method for producing a steroid hormone precursor, comprising the steps of: a) contacting the P450 enzyme of claim 1 with an isolated adrenodoxin (Adx) polypeptide, an isolated adrenodoxin reductase (AdR) polypeptide and a substrate selected from the group consisting of polycyclic and unsaturated mono alcohols having an aliphatic side chain such as cholesterol, a cholesterol analogue and a cholesterol derivative in conditions allowing the transformation of said substrate into a steroid hormone precursor, and b) recovering the steroid hormone precursor. 5. The method according to claim 4 , wherein the steroid hormone precursor is pregnenolone. 6. The enzyme according to claim 1 , wherein said amino acid sequence is at least 98% identical to SEQ ID NO: 1. 7. The enzyme according to claim 1 , wherein said amino acid sequence is at least 99% identical to SEQ ID NO: 1.

Assignees

Inventors

Classifications

  • Preparation of steroids · CPC title

  • acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title

  • for yeasts · CPC title

  • Steroid 11-beta-monooxygenase (1.14.15.4) · CPC title

  • C12N9/0079Primary

    Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9765307B2 cover?
The present invention pertains to an isolated P450 enzyme comprising or consisting of an amino acid sequence at least 80% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at position corresponding to position 225 and/or an aspartic acid mutation at position corresponding to position 289. The invention also concerns an isolated nucleic acid comprising a sequence encoding sa…
Who is the assignee on this patent?
Sanofi Sa
What technology area does this patent fall under?
Primary CPC classification C12N9/0079. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).